Contact Us | Useful Links | FAQs | Feedback | Sitemap |
 
   
 
An integrated strategy for the advancement of the Drug Holding Company :: The Ministry of Public Business Sector announces :: Holdipharma: Providing medical supplies to the hospitals of the Ministry of Health :: The National Bank and HoldiPharma sign a cooperation protocol :: Medicines Holding: We are not a party to the crisis of high alcohol prices ... ::
 
 
Company Details
Company Name   Website
Misr   www.misrpharma.com.eg
     
Description

Misr Company for pharmaceutical industries was founded in 1939 as the first Egyptian company for the pharmaceutical production of human and veterinary drugs, and it was totally financed by a pure Egyptian capital through the contribution of "Misr Bank " that was established by the Great Egyptian economist "Talaat Pasha Harb" to be the first nucleus for developing the national projects and for the creation  of an Egyptian industry to compete against the foreign goods that were controlling the Egyptian and Arab Markets at that time.

In 1956, the company had established a new facility at Matariya area in accordance to the latest industrial system requirements and was provided with the latest machinery automation needed for the establishment of modern pharmaceutical industry.

The company played a very important national role in providing the Egyptian army with its medicinal needs during the several wars carried out by Egypt besides fulfilling its national duty by providing medicinal demands for all the Arab and African countries.

Misr is an owned state Company and one of the affiliated companies to Holdipharma company.

 And to help the company to continue its successful history initiated by the Egyptian leaders,it was decided to demolish its main headquarter in Matariya and  go through a complete renovation and modernization by the establishment of a new factory at Abu Zaabal district outside the densely populated area and in accordance to the latest GMP requirements and to be able to apply  the international quality standards with  a fully equipped production lines.

Misr Company is uniquely characterized by the existence of a dedicated manufacturing line for the production of penicillins (β-lactam antibiotics) with all its dosage forms to serve most of pharmaceutical companies as a toll manufacturer for this specialized production.

Misr company also owes a modernized well-equipped sterile areas built in accordance to the highest level of quality to manufacture ampoules, drops, sterile eye ointments and specialized surgical ampoules like morphine and pethidine , that are produced with complete control to ensure the quality and safety and with affordable price.

Misr Company as a core company started to export its pharmaceutical products since the forties of the last century that was widely created as a good distinguished reputation in the Arab and African pharmaceutical market.

--------------

products company catalog

download

products company profile

download

Board Members:

 

Dr/ Yasser mohamed fawzy elkalway                                     Managing Director

Dr/Ahmed said mohamed elgezaoy                                           Chairman of the Board 

Dr / khaled  atef  elmaniery                                                             Member

Mr/    Tamer mohamed hussen                                                        Member

Mr/ Ahmed Alaa eldeen sad ahmed                                               Elected Member

 

Audit Committee:

Dr/Ahmed elgezaoy                                                                        Chairman

Dr / khaled  atef  elmaniery                                                             Member

Mr/    Tamer mohamed hussen                                                         Member

Mr/ Mohamed  mahmoud ali                                                              Member

Mr/ Sameh galeeby                                                                           Member

 

 

 

Company Main Indicators (in thousands of Egyptian Pounds)

Indicator

2018-2019

2019-2020

     2020-2021

Net Operating Revenue

345348

   425074

            427879

Interest Expenses

   0

   0

            0

Net Income

   4228

   35032

               56021

Net Equity

263012

   298043

             332427

Working Capital

   70198

   113032

               149864

Total Investment

  266025

   58721

               807425

Salaries

   108538

   116089

                113921

Number of workers

  1679

   1624

                 1572

     
Image Gallery
   
     
Related Links
Affiliates
   
Joint Venture
   
   
   
   
 
 
     
  Copyright © 2009 HOLDIPHARMA. All rights reserved.         Terms of Use | Privacy Statement | Disclaimer |